Clinical study of probiotics in the treatment of fever with thrombocytopenia syndrome

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2400090368

Enrollment

Unknown

Registered

2024-09-29

Start date

2024-10-01

Completion date

Unknown

Last updated

2024-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

severe fever with thrombocytopenia syndrome

Interventions

Test group:Probiotic therapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: If the patient is clearly diagnosed with SFTS, the subject or legal representative has signed the informed consent form.

Exclusion criteria

Exclusion criteria: Patients with known hypersensitivity to the study drug or active ingredient; Patients with other severe systemic disorders or psychosis.

Design outcomes

Primary

Measure	Time frame
Frequency of diarrhea; Stool routine;Gut Microbiome;Secondary infection;	—

Countries

China

Contacts

Public ContactLifen,Hu

The First Affiliated Hospital of Anhui Medical University

lifen.hu@163.com+86 138 5519 9430

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026